ArticlebioRxiv : the preprint server for biology2026
SR2P: an efficient stacking method to predict protein abundance from gene expression in spatial transcriptomics data.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Spatial transcriptomics data are largely available with RNA expression alone, limiting the detection of cell states defined by surface protein abundance. The lack of multi-omics spatial data limits the ability to identify immune cells and their signaling in the tumor microenvironment, as most solid tumors are immunologically poor and exhibit protein-RNA abundance discordance in critical immune cell surface markers. Although emerging technologies enable spatial multi-omics profiling, technical and cost constraints remain a hurdle. We introduce SR2P, a stacking-based machine-learning framework for predicting spatial protein abundance from RNA expression. SR2P integrates 11 complementary predictive models and consistently outperforms existing methods across multiple spatial multi-omics benchmark. We showcased an application of SR2P recovered macrophage-enriched regions and identified potential immune markers associated with therapeutic response from head-and-neck squamous cell carcinoma patients. SR2P enables protein-abundance inference from RNA-only spatial data, extending the analytical capabilities of current spatial platforms for studies of tumor immunology.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.